πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

CORCEPT THERAPEUTICS Patents

Full USPTO pharma patent portfolio for CORCEPT THERAPEUTICS β€” grant dates, expiration, and drug cross-links.

Patents
120
Expiring ≀24m
3

Quick answer

CORCEPT THERAPEUTICS has 120 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months β€” use filters for patent-cliff planning.

Page 3 of 3

  1. US 8859774

    Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8829024

    Combination steroid and glucocorticoid receptor antagonist therapy

    Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8741880

    Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

    Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8685973

    Pyrimidine cyclohexyl glucocorticoid receptor modulators

    Expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8598154

    Pyridyl-amine fused azadecalin modulators

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8598149

    Optimizing mifepristone levels in plasma serum of patients suffering from mental disorders treatable with glucocorticoid receptor antagonists

    Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8557839

    Fused ring azadecalin glucocorticoid receptor modulators

    Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8476254

    Methods for treating psychosis associated with interferson-Ξ± therapy

    Expires Mon Jun 27 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8461172

    Solid forms and process for preparing

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8450379

    Methods for treating migraine

    Expires Mon May 23 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8324203

    Azadecalin glucocorticoid receptor modulators

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8173664

    Modified pyrimidine glucocorticoid receptor modulators

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8097606

    Antiglucocorticoids for the treatment of catatonia

    Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7928237

    Fused ring azadecalin glucocorticoid receptor modulators

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7884091

    Methods for treating delirium using glucocorticoid receptor-specific antagonists

    Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7678813

    Azadecalin Glucocorticoid receptor modulators

    Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7576076

    Modified pyrimidine glucocorticoid receptor modulators

    Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7402578

    Methods for inhibiting cognitive deterioration in adults with down's syndrome

    Expires Mon Jul 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7361646

    Methods for treating gastroesophageal reflux disease

    Expires Mon Apr 17 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7326697

    Methods for increasing the therapeutic response to electroconvulsive therapy

    Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7163934

    Methods for treating delirium glucocorticoid receptor-specific antagonists

    Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 6964953

    Methods for treating stress disorders using glucocorticoid receptor-specific antagonists

    Expires Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6680310

    Methods for preventing antipsychotic-induced weight gain

    Expires Mon Jan 15 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6620802

    Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist

    Expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does CORCEPT THERAPEUTICS have?

120 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do CORCEPT THERAPEUTICS patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.